Publication

Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues

Downloadable Content

Persistent URL
Last modified
  • 08/19/2025
Type of Material
Authors
    Giovana B Bampi, University of HamburgRobert Rauscher, University of HamburgSebastian Kirchner, University of HamburgKathryn Oliver, Emory UniversityMarcel JC Bijvelds, Erasmus MC University Medical Center, RotterdamLeonardo A Santos, University of HamburgJohannes Wagner, University of HamburgRaymond A Frizzell, University of PittsburghHugo R de Jonge, Erasmus MC University Medical CenterEric Sorscher, Emory UniversityZoya Ignatova, University of Hamburg
Language
  • English
Date
  • 2020-11-01
Publisher
  • ELSEVIER
Publication Version
Copyright Statement
  • © 2020 European Cystic Fibrosis Society. Published by Elsevier B.V.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 19
Issue
  • 6
Start Page
  • 1021
End Page
  • 1026
Grant/Funding Information
  • Funding for this research was provided by the Cystic Fibrosis Foundation (OLIVER17F0 to KEO; IGNATO17XXO to ZI; SORSCH13XXO and SORSCH14XXO to EJS), National Institutes of Health (R01HL136414 to EJS), Burroughs Wellcome Fund (Collaborative Research Travel Grant to KEO), German Cystic Fibrosis Foundation muko e.V. (1603 to ZI).
Supplemental Material (URL)
Abstract
  • Background: Chronic inflammation is a hallmark among patients with cystic fibrosis (CF). We explored whether mutation-induced (F508del) misfolding of the cystic fibrosis transmembrane conductance regulator (CFTR), and/or secondary colonization with opportunistic pathogens, activate tissue remodeling and innate immune response drivers. Methods: Using RNA-seq to interrogate global gene expression profiles, we analyzed stress response signaling cascades in primary human bronchial epithelia (HBE) and intestinal organoids. Results: Primary HBE acquired from CF patients with advanced disease and prolonged exposure to pathogenic microorganisms display a clear molecular signature of activated tissue remodeling pathways, unfolded protein response (UPR), and chronic inflammation. Furthermore, CFTR misfolding induces inflammatory signaling cascades in F508del patient-derived organoids from both the distal small intestine and colon. Conclusion: Despite the small patient cohort size, this proof-of-principle study supports the use of RNA-seq as a means to both identify CF-specific signaling profiles in various tissues and evaluate disease heterogeneity. Our global transcriptomic data is a useful resource for the CF research community for analyzing other gene expression sets influencing CF disease signature but also transcriptionally contributing to CF heterogeneity.
Author Notes
Keywords

Tools

Relations

In Collection:

Items